About the Dermatopharmacologists Session
Dermatopharmacologists develop and test medications for skin, hair, and nail conditions. They research, formulate, and evaluate treatments for disorders such as acne, eczema, psoriasis, and skin infections. Their work involves understanding how different drugs interact with the skin and improving their absorption, effectiveness, and safety. Collaborating with dermatologists, pharmacologists, and researchers, they create topical creams, oral medications, and injectable treatments to manage and cure various skin conditions. Their work includes evaluating topical and systemic medications for conditions such as acne, eczema, psoriasis, and skin infections. By assessing drug formulations, absorption rates, and safety profiles, they help optimize treatments for maximum effectiveness while minimizing side effects. Innovations in nanotechnology, biotechnology, and transdermal drug delivery systems enhance targeted therapies for various skin disorders.
Dermatopharmacologists contribute to advancements in skincare and cosmetic dermatology by creating innovative treatments for anti-aging, hyperpigmentation, and scar reduction. They conduct clinical trials to assess the efficacy and safety of new dermatological drugs before they become widely available. Their research enhances existing treatments and helps develop targeted therapies for complex skin diseases, including autoimmune and genetic disorders. By combining knowledge in pharmacology and dermatology, dermatopharmacologists play a key role in ensuring patients have access to effective and safe treatments for both medical and cosmetic skin concerns.
Featured Speakers — Dermatopharmacologists 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Dermatopharmacologists Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Dermatopharmacologists Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Dermatopharmacologists work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Dermatopharmacologists research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same programme, same certificate.
Join IDC 2027 for the Dermatopharmacologists track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Dermatopharmacologists Conference 2027 — FAQs
What is the Dermatopharmacologists track at IDC 2027?
The Dermatopharmacologists track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Dermatopharmacologists. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Dermatopharmacologists sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Dermatopharmacologists are all welcome — whether presenting or attending.
Can I present my research in the Dermatopharmacologists track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Dermatopharmacologists sessions?
Yes. IDC 2027 is a hybrid conference — attend the Dermatopharmacologists track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

